Clinical Trials Browser

Phase 1/2 × Platinum × Genitourinary × Clear all

NCT05765084 2024-05-16

Immuno-MESODEC

Phase 1/2 Recruiting

GenitourinaryOther solid neoplasmThoracic

Mesothelioma, Malignant, Wilms Tumor

NCT01938573 2017-10-20

Sirolimus, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Bladder Cancer

Phase 1/2 Completed

21 enrolled 4 charts

Urinary Bladder Neoplasms